Concepedia

Tyler Levy

TL

9

Publications

1.5K

Citations

9

H-Index

2015

Active since

Affiliations

Cell Signaling Technology (United States)(Current)

Duke University

Harvard University

Broad Institute

Massachusetts General Hospital

Tyler Levy is an author at Cell Signaling Technology (United States) specializing in medicine, cell biology, and systems biology.

Top concepts

MedicineCell BiologySystems BiologyVirologyImmunologyCell SignalingMolecular BiologyViral PathogenesisSignal TransductionCovid-19

Publications per year

2015–2024

9

Publications

9

Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer’s disease

Yingyue Zhou, Wilbur M. Song, Prabhakar S. Andhey et al. · Nature Medicine · 2020 · 1.1K citations · Full text

Neurodegenerative Diseases, Molecular Neuroscience, Alzheimer's Disease +13

Host protein kinases required for SARS-CoV-2 nucleocapsid phosphorylation and viral replication

Tomer M. Yaron, Brook E. Heaton, Tyler Levy et al. · Science Signaling · 2022 · 89 citations · Full text

Viral Replication, Signal Transduction, Vaccine Development +14

Integration of protein phosphorylation, acetylation, and methylation data sets to outline lung cancer signaling networks

Mark L. Grimes, Benjamin Hall, Lauren Foltz et al. · Science Signaling · 2018 · 72 citations · Full text

Molecular Biology, Pathology, Multiomics +16

The FDA-approved drug Alectinib compromises SARS-CoV-2 nucleocapsid phosphorylation and inhibits viral infection in vitro

Tomer M. Yaron, Brook E. Heaton, Tyler Levy et al. · 2020 · 63 citations · Full text

Quantitative Profiling of Post-translational Modifications by Immunoaffinity Enrichment and LC-MS/MS in Cancer Serum without Immunodepletion

Hongbo Gu, Jian Ren, Xiaoying Jia et al. · Molecular & Cellular Proteomics · 2015 · 58 citations · Full text

Rows per page

1–5 of 9